[Federal Register Volume 67, Number 234 (Thursday, December 5, 2002)]
[Notices]
[Page 72425]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-30857]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Vaccinia Proteomics: Smallpox 
Vaccines and Antivirals.
    Date: December 19, 2002.
    Time: 9 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, NIAID, 6700-B Rockledge, 
Bethesda, MD 20892. (Telephone conference call.)
    Contact Person: Eleazar Cohen, PhD, Scientific Review 
Administrator, NIAID/DEA, Scientific Review Program, Room 2217, 
6700-B Rockledge Drive, MSC-7616, Rockville, MD 20892. 301-496-2550.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 26, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-30857 Filed 12-4-02; 8:45 am]
BILLING CODE 4140-01-M